Tourmaline Bio Stock Quote TRML - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

18.0416

Bid

17.99

Ask

18.08

Volume

147,623

17.54 Day's Range 18.195

12.12 52 Week Range 48.31

Market Cap

462.634M

Previous Close

17.33

Open

17.54

Last Trade

17.99

Last Trade Time

12:38:37

Financial Volume

$ 2,630,410

VWAP

17.8184

Average Volume (3m)

193,316

Shares Outstanding

25,642,610

Dividend Yield

PE Ratio

-10.94

Earnings Per Share (EPS)

-1.64

Revenue

Net Profit

-42.12M

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

talaristx.com

Headquarters

Wilmington, Delaware, USA

Founded

Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was $17.33. Over the last year, Tourmaline Bio shares have traded in a share price range of $ 12.12 to $ 48.31.

Tourmaline Bio currently has 25,642,610 shares outstanding. The market capitalization of Tourmaline Bio is $444.39 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -10.94.

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

Form 8-K - Current report

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

– Phase 2 TRANQUILITY trial surpasses enrollment target, with 143 total patients enrolled; topline data expected in second quarter of 2025 – – Deepak L. Bhatt, MD, MPH, MBA and Dipender Gill, MD...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.1884	-6.17992719709	19.23	20.21	17	289732	18.61591255	CS
4	-2.1584	-10.6851485149	20.2	22.21	17	222129	19.97758762	CS
12	-9.5484	-34.6081913737	27.59	29.6461	17	193316	23.1633757	CS
26	2.4216	15.5032010243	15.62	29.7883	13.03	195074	22.33067548	CS
52	-13.9084	-43.5317683881	31.95	48.31	12.12	288305	22.73115089	CS
156	7.7216	74.8217054264	10.32	48.31	9.18	256212	22.5494412	CS
260	7.7216	74.8217054264	10.32	48.31	9.18	256212	22.5494412	CS

TRML - Frequently Asked Questions (FAQ)

What is the current Tourmaline Bio share price?

The current share price of Tourmaline Bio is $ 18.0416

How many Tourmaline Bio shares are in issue?

Tourmaline Bio has 25,642,610 shares in issue

What is the market cap of Tourmaline Bio?

The market capitalisation of Tourmaline Bio is USD 444.39M

What is the 1 year trading range for Tourmaline Bio share price?

Tourmaline Bio has traded in the range of $ 12.12 to $ 48.31 during the past year

What is the PE ratio of Tourmaline Bio?

The price to earnings ratio of Tourmaline Bio is -10.94

What is the reporting currency for Tourmaline Bio?

Tourmaline Bio reports financial results in USD

What is the latest annual profit for Tourmaline Bio?

The latest annual profit of Tourmaline Bio is USD -42.12M

What is the registered address of Tourmaline Bio?

The registered address for Tourmaline Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Tourmaline Bio website address?

The website address for Tourmaline Bio is talaristx.com

Which industry sector does Tourmaline Bio operate in?

Tourmaline Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDMDBaird Medical Investment Holdings Ltd	$ 9.69 (78.78%)	13.93M
NUKKNukkleus Inc	$ 33.43 (62.83%)	16.52M
GSITGSI Technology	$ 3.96 (44.00%)	72.56M
CRKNCrown Electrokinetics Corporation	$ 0.1139 (42.91%)	329.59M
VSVersus Systems Inc	$ 2.73 (42.19%)	61.23M
PMAXPowell Max Ltd	$ 0.6637 (-20.02%)	2.54M
LGCBLinkage Global Inc	$ 0.30 (-18.92%)	544.33k
SHOTWSafety Shot Inc	$ 0.1855 (-17.56%)	3.36k
BLRXBioLineRx Ltd	$ 0.10235 (-16.04%)	21.65M
AENTAlliance Entertainment Holding Corporation	$ 4.99 (-15.99%)	102.78k
GCTKGlucoTrack Inc	$ 0.1024 (38.75%)	401.33M
CRKNCrown Electrokinetics Corporation	$ 0.1139 (42.91%)	329.59M
TGLTreasure Global Inc	$ 0.2752 (28.42%)	249.78M
RIMEAlgorhythm Holdings Inc	$ 0.0432 (2.13%)	235.78M
NVDANVIDIA Corporation	$ 137.86 (3.21%)	112.5M